Immatics (IMTX) Free Cash Flow (2019 - 2025)
Immatics' (IMTX) quarterly Free Cash Flow came in at -$67.2 million in Q4 2025, down 10.64% year-on-year from -$75.2 million in Q4 2024, and down 31.72% quarter-over-quarter from -$51.0 million in Q3 2025.
Immatics (IMTX) Free Cash Flow (2019 - 2025) Analysis & Trends
Immatics has disclosed Free Cash Flow across 7 years of filings, most recently posting -$67.2 million for Q4 2025.
- Free Cash Flow for Q4 2025 came in at -$67.2 million, down 10.64% year-over-year; the trailing twelve-month figure through Dec 2025 was -$193.5 million (down 26.41% YoY), and the FY2025 annual result was -$192.1 million, down 26.84% from the prior year.
- Free Cash Flow came in at -$67.2 million for Q4 2025 at Immatics, down from -$51.0 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $121.8 million in Q1 2022 to a low of -$67.2 million in Q4 2025.
- The 5-year median for Free Cash Flow is -$25.8 million (2023), against an average of -$17.2 million.
- Across the five-year window, Free Cash Flow surged 727.62% in 2022 and sank 841.82% in 2024, its largest moves.
- Immatics' Free Cash Flow stood at -$26.8 million in 2021, then sank by 54.43% to -$41.4 million in 2022, then jumped by 169.58% to $28.8 million in 2023, then tumbled by 310.72% to -$60.7 million in 2024, then retreated by 10.64% to -$67.2 million in 2025.
- The last three Free Cash Flow figures came in at -$67.2 million (Q4 2025), -$51.0 million (Q3 2025), and -$42.6 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 63,220.27 |
| 10 | Immatics | 14.67 Bn | 14.67 Bn | - | -67.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -67.16 Mn |
| Dec 31, 2025 | -67.16 Mn |
| Sep 30, 2025 | -50.99 Mn |
| Sep 30, 2025 | -50.99 Mn |
| Jun 30, 2025 | -42.59 Mn |
| Jun 30, 2025 | -42.59 Mn |
| Mar 31, 2025 | -32.75 Mn |
| Mar 31, 2025 | -32.75 Mn |
| Dec 31, 2024 | -60.70 Mn |
| Dec 31, 2024 | -60.70 Mn |
| Sep 30, 2024 | -33.97 Mn |
| Sep 30, 2024 | -33.97 Mn |
| Jun 30, 2024 | -32.95 Mn |
| Jun 30, 2024 | -32.95 Mn |
| Mar 31, 2024 | -25.45 Mn |
| Mar 31, 2024 | -25.45 Mn |
| Dec 31, 2023 | 28.81 Mn |
| Dec 31, 2023 | 28.81 Mn |
| Sep 30, 2023 | -26.15 Mn |
| Sep 30, 2023 | -26.15 Mn |